Jesy Nelson Celebrates National Expansion of SMA Newborn Screening Programme
Traveloasisspot.com – Former Little Mix vocalist Jesy Nelson has expressed her joy following the announcement that spinal muscular atrophy screening will be implemented nationwide across England. The singer had previously criticized the existing system as creating unfair disparities based on geographic location, describing it as a “postcode lottery” that left some families without equal access to vital testing.
Nelson’s advocacy work intensified after her twin daughters, Ocean Jade and Story Monroe Nelson, received diagnoses of this rare genetic disorder. SMA progressively weakens muscles over time, potentially preventing affected infants from achieving basic developmental milestones such as sitting independently or crawling. In its most serious manifestations, the condition can compromise breathing and swallowing functions entirely.
A Milestone for Families Across England
The Department of Health revealed on Thursday that the comprehensive newborn screening initiative will commence its national rollout as part of an ongoing evaluation framework beginning toward the end of the current year. This expansion represents a significant advancement for thousands of families who have long awaited equitable access to early detection.
Through a straightforward heel prick blood test administered shortly after birth, hundreds of thousands of infants will receive screening for SMA. The programme will continue expanding its reach throughout 2027, ensuring that every newborn testing laboratory within the United Kingdom eventually provides this crucial assessment.
After years of campaigning, it means so much to see the heel prick test for SMA begin rolling out from October, with implementation continuing throughout 2027 until every newborn screening laboratory across the UK is offering the test.
Knowing that future families will have access to early diagnosis and the opportunity for the best possible outcomes is something I’m incredibly proud to have supported.
This is a victory for every family affected by SMA. Whilst it can’t change the future of our children, I know it marks the beginning of a brighter future for future SMA families.
Overcoming Geographic Barriers
During a recent Instagram post featuring an emotional video message, Nelson reflected on a prior announcement indicating that October screening would initially reach only 72 percent of England. She emphasized that this incomplete coverage meant certain babies would miss out on testing purely due to their place of residence.
That means some babies won’t be screened simply because of where they live. A postcode lottery like that just isn’t fair.
Every baby deserves the same chance, every baby’s life matters.
The latest development ensures complete geographic coverage across England within the evaluation phase. Results from this comprehensive assessment will guide subsequent recommendations regarding newborn testing procedures established by the UK National Screening Committee.
Industry and Government Response
Giles Lomax, chief executive officer of Spinal Muscular Atrophy UK, praised the announcement as a transformative moment following extensive advocacy efforts. He highlighted that thousands of infants would benefit from earlier identification and access to treatments capable of fundamentally altering disease progression.
When newborn screening for SMA begins later this year in October, thousands of babies will benefit from earlier diagnosis and access to life-changing treatment.
We are delighted to see the confirmation that the remaining six screening laboratories will begin screening from October 2027, this demonstrates a clear commitment to making newborn screening available across England.
No family should face a postcode lottery when it comes to a condition where every day without treatment can lead to irreversible loss of motor neurons.
We are incredibly grateful to the families, clinicians, researchers, supporters and campaigners who have helped us reach this point, and we look forward to the day when every newborn across the whole of the UK is offered this simple, life-changing test.
Health Secretary James Murray echoed these sentiments, noting that parents should never witness their children losing fundamental abilities when earlier intervention could have prevented such outcomes. He described the expansion as another positive step toward reducing health inequalities throughout the nation.
No parent should have to watch their child lose the ability to move or breathe, knowing that earlier treatment could have made all the difference.
This expansion means babies across England will be tested from birth, giving them the best possible chance of a full and healthy life, and another step in the right direction as we do all we can to reduce health inequalities.
I’m in awe of the campaigners who’ve worked tirelessly to raise awareness of this rare but very serious genetic condition. We’re moving faster and rolling screening out more widely to ensure children get the best treatment from the earliest possible moment.
Meanwhile, Scotland is developing a comparable screening initiative utilizing private sector funding. The Department of Health and Social Care is pursuing a parallel strategy, seeking approximately £5 million in additional investment to broaden the evaluation programme’s scope and effectiveness across the country.
